HarbourVest Global Priv. Equity Ltd Appointment of Director (1818M)

TIDMHVPE

RNS Number : 1818M

HarbourVest Global Priv. Equity Ltd

20 May 2022

20 May 2022

Appointment of Director

HarbourVest Global Private Equity Limited ("HVPE" or the "Company"), a FTSE 250 investment company with global exposure to private companies, managed by HarbourVest Partners , today announces that Anulika Ajufo will join the Board as an Independent Non-Executive Director with effect from 19 May 2022.

Anulika is currently a Venture Partner at Sagana Group, Chair of the Board of Governors at the University of East London, a role she has held since November 2019, and a Non-Executive Director at Advantage Creative CIC, an Impact Investment Fund.

Prior to this, Anulika spent 15 years working at several financial services businesses, including the Soros Economic Development Fund, The Carlyle Group, and Goldman Sachs International. In these roles she gained significant experience of capital raising and investment across a variety of sectors.

Commenting on the appointment, Ed Warner, Chair of HVPE, said:

"I am delighted to welcome Anulika to the Board of HVPE. She brings with her broad and relevant experience from working in the investment industry, and I believe this will prove highly valuable to the Company. The Board and I look forward to working closely with Anulika over the coming years."

Anulika has no other listed company directorships.

There are no further details required to be disclosed pursuant to Listing Rule 9.6.13 R (2) to (6) inclusive.

Enquiries:

 
 
   Shareholders 
 Richard Hickman          Tel: [phone]   [e-mail] 
                           9847 
 Charlotte Edgar          Tel: [phone]   [e-mail] 
                           9826 
 
   Media 
 MHP Communications 
 Charlie Barker /         Tel: [phone]   [e-mail] 
  Robert Collett-Creedy    8540 
 

Notes to Editors:

About HarbourVest Global Private Equity Limited:

HarbourVest Global Private Equity Limited ("HVPE" or the "Company") is a Guernsey-incorporated, closed-end investment company which is listed on the Main Market of the London Stock Exchange and is a constituent of the FTSE 250 index. HVPE is designed to offer shareholders long-term capital appreciation by investing in a private equity portfolio diversified by geography, stage of investment, vintage year, and industry. The Company invests in and alongside HarbourVest-managed funds which focus on primary fund commitments, secondary investments and direct co-investments in operating companies. HVPE's investment manager is HarbourVest Advisers L.P., an affiliate of HarbourVest Partners, LLC, an independent, global private markets asset manager with 40 years of experience.

About HarbourVest Partners, LLC:

HarbourVest is an independent, global private markets investment specialist with 40 years of experience and more than $92 billion in assets under management, as of December 31, 2021. The Firm's powerful global platform offers clients investment opportunities in private equity, private credit, and infrastructure and real assets through primary fund investments, secondary investments, and direct co-investments, in commingled funds or separately managed accounts. HarbourVest has more than 800 employees, including more than 190 investment professionals across Asia, Europe, and the Americas. This global team has committed more than $49 billion to newly-formed funds, completed over $40 billion in secondary purchases, and invested over $27 billion directly in operating companies. Partnering with HarbourVest, clients have access to customized solutions, longstanding relationships, and actionable insights.

This announcement is for information purposes only and does not constitute or form part of any offer to issue or sell, or the solicitation of an offer to acquire, purchase or subscribe for, any securities in any jurisdiction and should not be relied upon in connection with any decision to subscribe for or otherwise acquire any Shares. In particular, this announcement does not constitute or form part of any offer to issue or sell, or the solicitation of an offer to acquire, purchase or subscribe for, any securities in the United States or to US Persons (as defined in Regulation S under the US Securities Act of 1933, as amended ("US Persons")). Neither this announcement nor any part of it shall form the basis of or be relied on in connection with or act as an inducement to enter into any contract or commitment whatsoever. Neither this announcement nor any copy of it may be taken, released, published, transmitted or distributed, directly or indirectly to US Persons or into the United States (including its territories and possessions), Canada, Australia or Japan, or any jurisdiction where such action would be unlawful. Any failure to comply with this restriction may constitute a violation of applicable law. Accordingly, recipients represent that they are able to receive this announcement without contravention of any applicable legal or regulatory restrictions in the jurisdiction in which they reside or conduct business. No recipient may distribute, or make available, this announcement (directly or indirectly) to any other person. Recipients of this announcement should inform themselves about and observe any applicable legal requirements in their jurisdictions.

The Shares have not been and will not be registered under the US Securities Act of 1933, as amended (the "Securities Act") or with any securities or regulatory authority of any state or other jurisdiction of the United States and, accordingly, may not be offered, sold, exercised, resold, transferred, delivered or distributed, directly or indirectly, within the United States or to US Persons. In addition, the Company is not, and will not be, registered under the US Investment Company Act of 1940, as amended (the "Investment Company Act") and shareholders of the Company will not have the protections of that act. There will be no public offer of the Shares in the United States or to US Persons.

This announcement has been prepared by the Company and its investment manager, HarbourVest Advisers L.P. (the "Investment Manager"). No liability whatsoever (whether in negligence or otherwise) arising directly or indirectly from the use of this announcement is accepted and no representation, warranty or undertaking, express or implied, is or will be made by the Company, the Investment Manager or any of their respective directors, officers, employees, advisers, representatives or other agents ("Agents") for any information or any of the opinions contained herein or for any errors, omissions or misstatements. None of the Investment Manager nor any of their respective Agents makes or has been authorised to make any representation or warranties (express or implied) in relation to the Company or as to the truth, accuracy or completeness of this announcement, or any other written or oral statement provided. In particular, no representation or warranty is given as to the achievement or reasonableness of, and no reliance should be placed on any projections, targets, estimates or forecasts contained in this announcement and nothing in this announcement is or should be relied on as a promise or representation as to the future.

The ongoing spread of the Coronavirus has had and will continue to have a material adverse impact on local economies in the affected jurisdictions and also on the global economy as cross-border commercial activity and market sentiment are increasingly impacted by the outbreak and government and other measures seeking to contain its spread. In addition to these developments having potentially adverse consequences for underlying portfolio investments of the HarbourVest funds and the value of the investments therein, the operations of HVPE, the Investment Manager, and HVPE's portfolio of HarbourVest funds have been, and could continue to be, adversely impacted and could materially and adversely affect the Investment Manager's ability to source, manage and divest its investments and its ability to fulfil its investment objectives. Similar consequences could arise with respect to other comparable infectious diseases.

Other than as required by applicable laws, the Company gives no undertaking to update this announcement or any additional information, or to correct any inaccuracies in it which may become apparent and the distribution of this announcement. The information contained in this announcement is given at the date of its publication and is subject to updating, revision and amendment. The contents of this announcement have not been approved by any competent regulatory or supervisory authority.

This announcement is issued by the Company, whose registered address is BNP Paribas House, St Julian's Avenue, St Peter Port, Guernsey, GY1 1WA

(c) 2022 HarbourVest Global Private Equity Limited. All rights reserved.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

BOAUKRWRUAUVAAR

(END) Dow Jones Newswires

May 20, 2022 02:01 ET (06:01 GMT)